A phase 3 clinical trial finds the SGLT2 inhibitor canagliflozin significantly improves glycemic...
Author - Hippocrates Briefs Team
A Data-Driven Reclassification of Multiple Sclerosis Defines a...
A groundbreaking AI model redefines multiple sclerosis not as distinct subtypes but as a single...
Thirty-Eight-Year Analysis of Pediatric Heart Transplantation in...
A 38-year study of Nordic pediatric heart transplantation reveals a significant decline in waiting...
Fluorescent Probes Map Cellular Targets of GLP1R/GIPR Dual...
New fluorescent chemical tools reveal for the first time how potent dual-agonist drugs for diabetes...
Key Updates in the 2025 High Blood Pressure Guideline: New...
The new 2025 hypertension guideline updates clinical practice with the PREVENT risk calculator...
COVID-19 Associated with Accelerated Vascular Aging...
An extensive international study reveals that COVID-19 infection is linked to accelerated vascular...
Atherosclerotic Ischemia Reprograms Hematopoiesis to Promote...
New research reveals how restricted blood flow from cardiovascular disease can reprogram the immune...
Hemodynamic Impact of “Clear” E-Cigarettes with...
New research shows that "clear" e-cigarettes contain synthetic coolants and cause greater acute...
A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia:...
A clinical trial reveals that a liquid fat supplement, triheptanoin, significantly improves...
A Systematic Review of Medication-Related Breastfeeding...
A new study reveals that many mothers are receiving incorrect advice and stopping breastfeeding...